Selected article for: "clinical relevance and current evidence"
Author: Schultheiss, Heinz-Peter; Baumeier, Christian; Pietsch, Heiko; Bock, C Thomas; Poller, Wolfgang; Escher, Felicitas
Title: Cardiovascular consequences of viral infections: from COVID to other viral diseases
  • Cord-id: j903dje2
  • Document date: 2021_10_5
    • ID: j903dje2
    Snippet: Infection of the heart muscle with cardiotropic viruses is one of the major etiologies of myocarditis and acute and chronic inflammatory cardiomyopathy (DCMi). However, viral myocarditis and subsequent dilated cardiomyopathy (DCM) is still a challenging disease to diagnose and to treat and is therefore a significant public health issue globally. Advances in clinical examination and thorough molecular genetic analysis of intramyocardial viruses and their activation status have incrementally impro
    Document: Infection of the heart muscle with cardiotropic viruses is one of the major etiologies of myocarditis and acute and chronic inflammatory cardiomyopathy (DCMi). However, viral myocarditis and subsequent dilated cardiomyopathy (DCM) is still a challenging disease to diagnose and to treat and is therefore a significant public health issue globally. Advances in clinical examination and thorough molecular genetic analysis of intramyocardial viruses and their activation status have incrementally improved our understanding of molecular pathogenesis and pathophysiology of viral infections of the heart muscle. To date, several cardiotropic viruses have been implicated as causes of myocarditis and DCMi. These include, among others, classical cardiotropic enteroviruses (coxsackieviruses B), the most commonly detected parvovirus B19, and human herpes virus 6. A newcomer is the respiratory virus that has triggered the worst pandemic in a century, SARS-CoV-2, whose involvement and impact in viral cardiovascular disease is under scrutiny. Despite extensive research into the pathomechanisms of viral infections of the cardiovascular system, our knowledge regarding their treatment and management is still incomplete. Accordingly, in this review we aim to explore and summarize the current knowledge and available evidence on viral infections of the heart. We focus on diagnostics, clinical relevance and cardiovascular consequences, pathophysiology, and current and novel treatment strategies.

    Search related documents:
    Co phrase search for related documents
    • aav vector and lung injury: 1
    • aav vector and magnetic resonance: 1
    • absence presence and accessory protein: 1, 2
    • absence presence and accurate diagnosis: 1, 2, 3, 4, 5, 6, 7
    • absence presence and acid therapeutic: 1
    • absence presence and active infection: 1, 2, 3
    • absence presence and acute myocardial infarction: 1, 2
    • absence presence and acute myocarditis: 1
    • absence presence and acute phase: 1, 2, 3, 4, 5, 6, 7, 8
    • absence presence and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • absence presence and additional insight: 1
    • absence presence and adenovirus receptor: 1
    • absence presence and adjacent tissue: 1
    • absence presence and liver affect: 1
    • absence presence and lopinavir ritonavir: 1, 2
    • absence presence and lung injury: 1, 2, 3, 4
    • absence presence and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • accessory protein and acute respiratory distress syndrome: 1, 2, 3
    • accessory protein and lung injury: 1, 2